<DOC>
	<DOCNO>NCT01558505</DOCNO>
	<brief_summary>Drug-eluting balloon show positive result term restenosis reduction peripheral intervention ( PTA ) . The aim study investigate randomize fashion efficacy safety Paclitaxel-eluting balloon ( PEB ) ( In.Pact Amphirion , Invatec , Brescia , Italy ) versus non drug-eluting balloon ( NEB ) ( Amphirion deep , Invatec , Brescia , Italy ) diabetic patient Critical Limb Ischemia ( CLI ) undergo PTA below-the-knee ( BTK ) vessel .</brief_summary>
	<brief_title>Drug Eluting Balloon peripherAl inTErvention For Below The Knee Angioplasty Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<criteria>age &gt; 18 year angiographic stenosis &gt; 50 % occlusion one belowknee vessel allergy Paclitaxel contraindication combine antiplatelet treatment life expectancy &lt; 1 year hypersensitivity contraindication one study drug lack consent need amputation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>drug-eluting balloon</keyword>
	<keyword>restenosis</keyword>
</DOC>